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Reaction Mixtures Through Liquid-Liquid Segmented Flow
Processes
Niklas Adebar,[a] Ji Eun Choi,[a] Lukas Schober,[a] Ryoma Miyake,[b] Takanobu Iura,[b, c]
Hiroshi Kawabata,[b, c] and Harald Gröger*[a]
Biphasic biocatalytic reactions have gained much attention in
the field of enzyme-catalysed synthesis. As most components
being of relevance for the pharmaceutical industry are hydro-
phobic, often biphasic reaction media turned out to be the
solvent system of choice. However, in spite of successful
reaction courses practical difficulties in the downstream-proc-
essing, in particular extremely difficult phase separations due to
emulsification and precipitation, represent a challenge to over-
come in process development. In this work, we report our
studies on the benefits of a simple flow set-up being capable to
minimise such work-up limitations. In detail, a segmented flow
system based on a biphasic MTBE/buffer mixture was success-
fully applied for two types of enzymatic reductions of a
hydrophobic ketone in the presence of an alcohol dehydrogen-
ase (ADH) as an enzyme class being known for their excellent
enantioselectivity and successful utilization in the synthesis of a
range of active pharmaceutical ingredients. The applicability of
this flow system was demonstrated with two different enzymes
as well as different substrates. Besides an ADH from Lactoba-
cillus brevis, an ADH from Ogatea minuta was utilized for the
reduction of acetophenone and 2,2,2-trifluoroacetophenone,
respectively.
A range of impressive achievements in the field of biocatalysis
have been made during past decades with respect to finding
new enzymes, reactions and modification of enzymes using
various techniques from different fields, such as protein
engineering and immobilization.[1,2] In addition, process devel-
opment represents an important task when it comes to
industrial applications. An emerging research theme in this field
are continuously running syntheses, which nowadays gained
more and more interest also for enzyme catalysis.[3–5] This trend
has been certainly stimulated by recent recommendations of
the U.S. Food and Drug Administration (FDA) as well as the
European Medicines Agency (EMA) for continuous manufactur-
ing, which were added to their regulatory guidelines.[6] Often,
the use of biphasic reaction systems offers advantages over the
use of monophasic reactions.[6] Since typically enzymes are less
stable in organic reaction media, but pharmaceutical com-
pounds often tend to be hydrophobic, a compromise must be
found. One of the favoured solutions is the use of an aqueous/
organic biphasic media, which turned out to be the reaction
medium of choice for numerous biotransformations. By leaving
the enzyme in its native aqueous environment and adding a
second, organic phase as substrate/product reservoir, the
enzyme stability should be less affected compared to the use of
a pure organic solvent. Thus, high substrate loadings can be
reached by means of a biphasic system while avoiding strong
deactivation of the enzyme.[2,7] Furthermore, downstream proc-
essing can be designed efficiently by means of phase
separation.[8] However, most examples of biphasic biocatalytic
reactions so far are limited to batch processes.[9] At the same
time, although this approach looks promising in theory, it raises
practical challenges and concerns. As many scientists might
have suffered on their own, formation of emulsions being
difficult to separate is a major issue when working with biphasic
biocatalytic reaction mixtures.[10]
In a pioneering work on the use of an alcohol dehydrogen-
ase (ADH; being an important enzyme class for the biocatalytic
synthesis of pharmaceuticals) for processes running in a flow
mode, Schmid and Buehler et al. recently investigated the
stability of a thermophilic ADH in a segmented flow system.[5a]
The same group also investigated this ADH-catalysed reduction
with a focus on mass transfer-limited reactions concluding that
mass transfer-limited reactions benefit from this type of
setup.[5b] As a further benefit of such a segmented flow process,
a better phase separation was mentioned by the authors of this
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study.[5b,c] Furthermore, flow systems turned out to provide
successful solutions for many types of phase-separation
challenges.[11]
Inspired by this pioneer work[5] of Schmid and Buehler and
the success of flow systems in general for solving phase-
separation challenges and due to the importance of an efficient
downstream process for technical purpose (besides achieving
an efficient reaction course and, e.g., high substrate loading),
we became interested to study to which extend enzymatic
ketone reductions running in a flow mode can benefit from
such a segmented flow-setup due to an improved work-up. In
particular we were interested to study the differences of phase-
separations when conducting such biotransformations in a
batch-mode and segmented flow-mode, respectively, exempli-
fied for different enzymes and different substrates.
Herein we report a simple, yet robust segmented flow
process simplifying and minimising work-up efforts and unit-
operation steps. We focused on favoured solvents and ketone
substrates as model compounds for pharmaceutically relevant
building blocks. As such a model reaction for an ADH-catalysed
reduction, at first the reduction of acetophenone (1) to (R)-1-
phenylethanol ((R)-2) in the presence of an alcohol dehydrogen-
ase from Lactobacillus brevis (LB-ADH)[12] was chosen as this
enzyme has been shown to be relatively tolerant towards
various organic solvents.[12] As the required cofactor NADPH is
an expensive compound, a cheap and efficient glucose
dehydrogenase (GDH)-based cofactor regeneration system[13]
was applied. This cofactor regeneration system is based on the
in situ-reduction of NADP+ through oxidation of glucose to
gluconolactone and a subsequent irreversible ring opening to
gluconic acid (see Scheme 1).
The aqueous phase was prepared by dissolving the ADH as
well as the cofactor NADPH and its in situ-cofactor regeneration
system consisting of GDH and glucose in phosphate buffer. The
substrate was dissolved in methyl tert-butyl ether (MTBE), thus
representing the organic counterpart to the buffer solution.
These two immiscible solutions were combined in a Y-shape
mixer, thus resulting in a continuous stream of uniform
segments. These segments were then inserted into a PFE coil
reactor (inner diameter 0.8 mm), in which the biotransformation
takes place. The set-up of this flow process is shown in Figure 1.
Afterwards, the reaction mixture was collected and immediately
quenched with HCl solution to avoid further reaction in the
collection vial. It should be added that when the reaction was
quenched to investigate the conversion after a certain reaction
time, precipitation and emulsification occurred again due to the
magnetic stirring in the collection vial.
The flow reaction shows two major practical advantages
over the analogous reaction conducted in batch mode: first, in
case of the flow reaction, an additional air-liquid interface,
occurring in batch reactions due to stirring, is avoided. Second,
mixing is changed from a vigorous stirring to a gentler mixing,
thus resulting in less protein aggregation and precipitation due
to reduced shear forces compared to the batch mode. As
shown in Figure 2, the phase separation after 1 h reaction time
for the batch process compared to the one for the flow process
after 2 h residence time (which represents the equivalent in
flow processes to the reaction time in batch processes) shows a
better phase separation for the flow process (right) in spite of
Scheme 1. ADH-catalysed reduction of acetophenone (1) to 1-phenylethanol
(R)-2 and trifluoroacetophenone (3) to the corresponding alcohols (R)-2 and
(R)-4 with GDH based cofactor regeneration system.
Figure 1. Schematic process of the segmented flow approach for the
enzymatic reduction of acetophenone (1) and trifluoroacetophenone (3) to
the corresponding alcohols (R)-2 and (R)-4 in a liquid-liquid segmented flow
system.
Figure 2. Phase separation of the reaction mixture compared for batch after
1 h reaction time (left) and developed flow process after 2 h residence time
(right) using LB-ADH.
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doubled reaction time. The batch reaction (left) led to
significantly worse separation even after resting for only 1 h.
Furthermore, after 3 h reaction/residence time (see Figure 3)
with threefold increased amount of catalyst and cofactor
regeneration system concentration, in the bathch process
emulsification and precipitation prevent a clear phase separa-
tion. In contrast, for the developed flow process the phase
boundary is clearly visible (Figure 3), and, thus, phase separa-
tion can be done easily.
When comparing the conversions obtained for the model
reaction in a flow and batch mode, respectively, no differences
between flow and batch process could be observed after a
certain reaction time (Figure 4). As the mixing, and therefore
the mass transfer, in segmented flow process is reported to be
significantly increased compared to batch processes, a mass
transfer limitation appears to be unlikely for the investigated
reaction, thus being in accordance with the literature.[5]
Whereas the reduction of acetophenone (1) in a batch
process gave a conversion of 32% to alcohol (R)-2 after 1 h
reaction time, a very similar conversion of 33% was obtained in
a flow mode under comparable reaction conditions (residence
time of 1 h and catalyst loading per overall volume of 1 U ·mL  1
for a 50 mM substrate solution when considering the total
volume). In this case, the enzyme loading in terms of amount of
biomass per reaction volume corresponds to approximately
30 μg of protein per mL of reaction mixture. As both, batch and
flow, processes perform similar, the enzyme activity per mmol
of substrate is identical.
To investigate the robustness and reliability of the devel-
oped flow process, the biotransformation running in the
“segmented flow mode” was repeated using the same reaction
conditions and we were pleased to find that the average
conversion (after 1 h equilibration time) turned out to be very
similar to the first experiment with conversions of 33% and
32%, respectively (Figure 5). It should be added that in general,
the equilibration time in our flow experiments was adjusted to
two times of the residence time (“equilibration time”) in order
to ensure a stable reaction system.
After having characterized the reaction, we were also
interested to increase the conversion of this segmented flow
process. We were pleased to find that by increasing the
biocatalyst loading per overall volume to 3 U ·mL  1 and the
residence time to 3 h, the conversion was significantly im-
Figure 3. Phase separation of the reaction mixture compared for batch after
3 h reaction time (left) and developed flow process after 3 h residence time
(right) using LB-ADH.
Figure 4. Comparison of conversion of acetophenone (1) to alcohol (R)-2 in
biphasic buffer/MTBE batch and flow processes. Both: csubtr.(overall): 50 mM,
cat. loading per overall volume: 1 U ·mL  1, reaction/residence time: 1 h.
Figure 5. Conversion of acetophenone (1) to 1-phenylethanol (R)-2 using LB-
ADH with a GDH-based cofactor recycling system in a buffer/MTBE
segmented flow system. Horizontal lines show conversion for fractions
collected between times indicated with dashed vertical lines. Reactor
volume: 0.5 mL (PFE, ID: 0.8 mm), residence time: 1 h, Y-mixer (ID: 1.01 mm),
cat. loading per overall volume: 1 U ·mL  1, temp.: rt, csubstr.(overall): 50 mM.
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proved achieving a maximum conversion to (R)-2 of 95%
(Figure 6). After an initial equilibration time, in which the
conversion was not yet stable, the system equilibrated to an
average of 93% conversion related to the formation of the
desired product (R)-2 with only a minor deviation of �2%
between the collected fractions. An extended run and a
recycling of the aqueous phase containing the biocatalysts and
cofactors represents a task for further research in the future.
As a next step we became interested to explore another
enzymatic reduction for such a flow process utilizing a different
enzyme (used at a different protein loading) in combination
with another ketone component. In detail, we chose an alcohol
dehydrogenase from Ogatea minuta (OM-ADH) as a further
recombinant biocatalyst, which has been recently reported and
characterized in terms of process stability.[14,15] This enzyme was
then used for the reduction of 2,2,2-trifluoroacetophenone (3)
to (R)-(  )-α-(trifluoromethyl)benzyl alcohol ((R)-4). This sub-
strate 3 was chosen since the OM-ADH showed a higher specific
activity towards 2,2,2-trifluoroacetophenone (3) compared to
acetophenone (1). The segmented flow reaction was then
conducted at a substrate concentration per overall volume of
100 mM of 2,2,2-trifluoroacetophenone (3) dissolved in MTBE as
organic solvent. Under the initial reaction conditions and after
the equilibration time, a constant conversion to the desired
alcohol (R)-4 of 48% was achieved (Figure 7A).
In order to improve the conversion, we increased the
enzyme loading from a biocatalyst amount per overall volume
of 5 U ·mL  1 (1.6 mg ·mL  1 lyophilised enzyme) to 10 U ·mL  1
(3.2 mg·mL  1 lyophilised enzyme) along with an increase of the
residence time up to 2 h. Applying these optimized reaction
conditions then resulted in a significantly increased conversion
to (R)-4 of approximately 70% conversion (Figure 7B).
As for the work-up after the biotransformation, compared to
the previously discussed LB-ADH-based reduction the phase
separation is less clear. However, it also must be taken into
account that the biomass loading is significantly increased
when using OM-ADH as biocatalyst, which then causes such an
emulsifying effect.
At the same time, it is noteworthy that also in this case of
OM-ADH-catalysed ketone reduction the phase separation is
still tremendously better for the developed flow process
compared to the conventional batch process as indicated by
the photos in Figure 8. Whereas an emulsion with no clear
phases results from the batch reaction (Figure 8A), still separa-
ble phases are obtained for the reaction mixture of the flow
process (Figure 8B).
In conclusion, we reported a comparison of phase separa-
tion of biphasic reaction mixtures when conducing enzymatic
ketone reductions in batch and flow mode. Toward this end,
two different types of biotransformation have been investigated
based on the use of two different alcohol dehydrogenases
(ADHs) as well as two different ketones. It turned out that while
Figure 6. Conversion of acetophenone (1) to 1-phenylethanol (R)-2 using LB-
ADH with a GDH-based cofactor recycling system in a buffer/MTBE
segmented flow system. Horizontal lines show conversion for fractions
collected between times indicated with dashed vertical lines. Reactor
volume: 0.5 mL (PFE, ID: 0.8 mm), residence time: 3 h, Y-mixer (ID: 1.01 mm),
cat. loading per overall volume: 3 U ·mmol  1, temp.: rt, csubstr.(overall): 50 mM.
Figure 7. Conversion of 2,2,2-trifluoroacetophenone to (R)-4 using OM-ADH
with a GDH-based cofactor regeneration system in a buffer/MTBE segmented
flow system. Horizontal lines show conversion for fractions collected
between times indicated with dashed vertical lines. Reactor volume: 1 mL
(PFE, ID: 0.8 mm), residence time: 1 h (A) and 2 h (B), Y-mixer (ID: 1.01 mm),
cat. loading per overall volume: 5 U ·mL  1 (1.6 mg ·mL  1 lyophilised enzyme)
(A) and 10 U ·mL  1 (3.2 mg ·mL  1 lyophilised enzyme) (B), temp.: 30 °C,
csubstr.(overall): 100 mM.
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conversions of the processes in batch and flow mode are similar
under comparable conditions (exemplified for the reduction
using the ADH from L. brevis), emulsification and precipitation
are strongly suppressed when carrying out the biocatalytic
reactions in a flow mode, thus significantly simplifying and
minimising work-up efforts for biphasic biocatalytic reaction
systems. It is further noteworthy that the flow systems can be
operated in a stable fashion for at least several hours. Currently,
further process optimization as well as extension of this type of
segmented flow process technology to other ADH-catalysed
reductions and other types of biotransformations running in an
aqueous-organic biphasic solvent system are in progress.
Further tasks of future work are an extended run as well as
recycling of the aqueous phase containing the enzymes and
cofactor.
Experimental Section
Typical Procedure for the Synthesis of (R)-1-Phenylethanol
((R)-2) in a Segmented Flow Process Utilizing an Alcohol
Dehydrogenase from Lactobacillus Brevis:
In a glass vial, an alcohol dehydrogenase from Lactobacillus brevis
(LB-ADH; 2 U),[12] a glucose dehydrogenase (GDH; 6 U),[16] glucose
solution (cfinal: 150 mM, 300 μL 1 M in KPi (100 mM, pH 7)), NADPH
(cfinal: 0.1 M, 20 μL 10 mM aqueous solution) and potassium
phosphate buffer (to 1 mL, 100 mM, pH 7) were mixed and trans-
ferred into a syringe (1 mL, S.G.E. gas tight, 4.7 mm ID). Acetophe-
none (1, cfinal: 50 mM, 11.7 μL, 0.1 mmol) was mixed with MTBE
(resulting in a total volume of 1 mL) and transferred into a syringe
(1 mL, S.G.E. gas tight, 4.7 mm inner diameter). Both syringes were
attached to a syringe pump and pumped (0.25 mL ·h  1 flow rate)
via a Y-mixer (0.51 mm ID) in a coil reactor (PFE, reactor volume:
0.5 mL, 0.8 mm inner diameter). Fractions of the resulting reaction
mixture were collected in glass vials containing an aqueous solution
of HCl (400 μL, 2 M). The fractions were diluted with ethyl acetate
(400 μL) and the organic phase was analysed via GC.
Typical Procedure for the Synthesis of
(R)-(  )-α-(Trifluoromethyl)benzyl Alcohol ((R)-4) in a
Segmented Flow Process Utilizing an Alcohol Dehydrogenase
from Ogatea Minuta:
Aqueous solution (3 mL) was prepared in a falcon tube containing
an alcohol dehydrogenase from Ogatea minuta (carbonyl reductase
from Ogatea minuta, OM-ADH; 10 U ·mL  1),[14,15] a glucose dehydro-
genase (GDH; 30 U ·mL  1),[16] 600 mM d-glucose, 2 mM NADP+, and
50 mM potassium phosphate buffer (pH 7.0) and transferred to
syringe (2.5 mL S.G.E., 7.28 mm inner diameter). Corresponding
protein concentration was 1.8 mg ·mL  1. Organic phase containing
200 mM 2,2,2-trifluoroacetophenone (3) in MTBE was prepared in a
falcon tube and transferred into a syringe (2.5 mL S.G.E., 7.28 mm
inner diameter). Both syringes were mounted on a syringe pump.
Aqueous solution and organic solution were pumped through a Y-
shape mixer (0.51 mm inner diameter) into a tubular reactor, which
has an inner diameter of 0.8 mm (PFE; reaction volume: 1 mL; flow
rate: 0.5 mL ·h  1). The reaction time was extended from 1 and 2 h
by lowering the flow rate to 0.25 mL ·h  1 with increment of OM-
ADH (20 U ·mL  1; 3.6 mg ·mL  1) and GDH (20 U ·mL  1). The reaction
mixture was quenched by addition of an aqueous solution of HCl
(0.5 mL, 1 M), followed by extraction with ethyl acetate (1 mL) for
GC analysis.
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